Loading
Yanuki
KEYWORD TOPIC
Bavarian Nordic Reports Strong Q1 2025 Growth Driven by Travel Health and Vaccine Sales | CDC Recommends Extra Measles Shot for Travelers Amid Outbreaks | Bavarian Nordic Reports Strong Q1 2025 Growth Driven by Travel Health and Vaccine Sales | CDC Recommends Extra Measles Shot for Travelers Amid Outbreaks

Health / Vaccines

Bavarian Nordic Reports Strong Q1 2025 Growth Driven by Travel Health and Vaccine Sales

Bavarian Nordic A/S (OMX: BAVA) has announced a strong start to 2025, with significant revenue growth driven by its Travel Health and Public Preparedness segments. The company reported a 62% increase in revenue for the first three months, r...

Bavarian Nordic Announces Interim Results for the First Three Months of 2025
Bavarian Nordic Reports Strong Q1 2025 Growth Driven by Travel Health and Vaccine Sales Image via GlobeNewswire
TOPIC travel health

Health / Vaccinations

CDC Recommends Extra Measles Shot for Travelers Amid Outbreaks

Amid rising measles cases globally and specific outbreaks in areas like Texas and Kansas, the U.S. Centers for Disease Control and Prevention (CDC) has updated its recommendations, advising an extra dose of the measles-mumps-rubella (MMR) v...